Best Practice & Research Clinical Rheumatology
Volume 23, Issue 5 , Pages 679-688 , October 2009

Update in paediatric vasculitis

  • Seza Özen (Professor of Pediatrics)

      Affiliations

    • Department of Pediatrics, Hacettepe University, Ankara, Turkey
    • ,
  • Robert C. Fuhlbrigge (Associate Professor of Pediatrics and Dermatology)

      Affiliations

    • Program in Pediatric Rheumatology, Division of Immunology, Children's Hospital- Boston, 300 Longwood Ave., Boston, MA 02115, United States
    • Corresponding Author InformationCorresponding author. Tel.: 617 525 8502; Fax: 617 264 5123.

References 

  1. Jennette JC, Falk RJ. Do vasculitis categorization systems really matter?. Curr Rheumatol Rep. 2000;2:430–438
  2. Fries JF, Hunder GG, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33:1135–1136
  3. Lie JT. Nomenclature and classification of vasculitis: plus ca change, plus c'est la meme chose. Arthritis Rheum. 1994;37:181–186
  4. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–192
  5. Ozen S, Anton J, Arisoy N, et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr. 2004;145:517–522
  6. Bakkaloglu A, Ozen S, Baskin E, et al. The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa. Arch Dis Child. 2001;85:427–430
  7. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936–941
  8. Ozen S., Pistorio A., Dolezalova, P., et al. (in press). The EULAR/PRINTO/PReS crıterıa for Wegener Granulomatosis. Ankara 2008. Ann Rheum Dis.
  9. Ozen S., Pistorio A., Iusan M., et al. (in press). The EULAR/PRINTO/PReS crıterıa for Henoch- Schonlein purpura. Ankara 2008. Ann Rheum Dis.
  10. Ozen, S., Pistorio, A., Iusan, M., et al. (in press). The EULAR/PRINTO/PReS crıterıa for chıldhood polyarterıtıs nodosa. Ankara 2008. Ann Rheum Dis.
  11. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222–227
  12. Jennette JC, Falk RJ. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol. 2008;20:55–60
  13. Borgmann S, Haubitz M. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides. Clin Exp Rheumatol. 2004;22:S79–86
  14. Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110:955–963
  15. Dedeoglu F, Sundel RP. Vasculitis in children. Rheum Dis Clin North Am. 2007;33:555–583
  16. Rowley AH, Baker SC, Orenstein JM, et al. Searching for the cause of Kawasaki disease–cytoplasmic inclusion bodies provide new insight. Nature Rev. 2008;6:394–401
  17. Coppo R, Amore A, Gianoglio B. Clinical features of Henoch-Schonlein purpura. Italian group of renal immunopathology. Ann Med Interne. 1999;150:143–150
  18. Burgner D, Davila S, Breunis WB, et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet. 2009;5:e1000319
  19. Cheung YF, Huang GY, Chen SB, et al. Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics. 2008;122:e608–614
  20. Yalcinkaya F, Ozcakar B, Kasapcopur A, et al. Prevalence of MEFV mutations in childhood PAN. J Pediatr. 2007;151:675–678
  21. Pipitone N, Salvarani C. Role of imaging in vasculitis and connective tissue diseases. Best Pract Res. 2008;22:1075–1091
  22. Binstadt BA, Levine JC, Nigrovic PA, et al. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics. 2005;116:e89–e93
  23. Sabatier F, Camoin-Jau L, Anfosso F, et al. Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med. 2009;13:454–471
  24. Watts R, Harper L, Jayne D, et al. Translational research in autoimmunity: aims of therapy in vasculitis. Rheumatology (Oxford). 2005;44:573–576
  25. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68:310–317
  26. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68:318–323
  27. Phillip R, Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol. 2008;26:S94–104
  28. Huber AM, King J, McLaine P, et al. A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein Purpura [ISRCTN85109383]. BMC Med. 2004;2:7
  29. Ronkainen J, Koskimies O, Ala-Houhala M, et al. Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2006;149:241–247
  30. Weiss PF, Feinstein JA, Luan X, et al. Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review. Pediatrics. 2007;120:1079–1087
  31. Chartapisak W, Opastiraku S, Willis NS, et al. Prevention and treatment of renal disease in Henoch-Schonlein purpura: a systematic review. Arch Dis Child. 2009;94:132–137
  32. Zaffanello M, Brugnara M, Franchini M. Therapy for children with henoch-schonlein purpura nephritis: a systematic review. ScientificWorldJournal. 2007;7:20–30
  33. Shenoy M, Bradbury MG, Lewis MA, et al. Outcome of Henoch-Schonlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol. 2007;22:1717–1722
  34. Zampetti A, Rigante D, Bersani G, et al. Longitudinal study of microvascular involvement by nailfold capillaroscopy in children with Henoch-Schonlein purpura. Clin Rheumatol. 2009;
  35. Falcini F. Kawasaki disease. Curr Opin Rheumatol. 2006;18:33–38
  36. Hsieh KS, Weng KP, Lin CC, et al. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Pediatrics. 2004;114:e689–e693
  37. Newburger JW, Sleeper LA, McCrindle BW, et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007;356:663–675
  38. Okada K, Hara J, Maki I, et al. Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease. Eur J Pediatr. 2009;168:181–185
  39. Furukawa T, Kishiro M, Akimoto K, et al. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Arch Dis Child. 2008;93:142–146
  40. Burns JC, Mason WH, Hauger SB, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr. 2005;146:662–667
  41. Nakamura Y, Aso E, Yashiro M, et al. Mortality among persons with a history of Kawasaki disease in Japan: can paediatricians safely discontinue follow-up of children with a history of the disease but without cardiac sequelae?. Acta Paediatr. 2005;94:429–434
  42. Tremoulet AH, Best BM, Song S, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008;153:117–121
  43. Brunner J, Freund M, Prelog M, et al. Successful treatment of severe juvenile microscopic polyangiitis with rituximab. Clin Rheumatol. 2009;
  44. Patel AM, Lehman TJ. Rituximab for severe refractory pediatric Wegener granulomatosis. J Clin Rheumatol. 2008;14:278–280
  45. Ozen S, Bakkaloglu A, Dusunsel R, et al. Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol. 2007;26:196–200
  46. Tann OR, Tulloh RM, Hamilton MC. Takayasu's disease: a review. Cardiol Young. 2008;18:250–259
  47. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008;47:403–408
  48. Benseler SM. Central nervous system vasculitis in children. Curr Rheumatol Rep. 2006;8:442–449
  49. Boyer D, Vargas SO, Slattery D, et al. Churg-Strauss syndrome in children: a clinical and pathologic review. Pediatrics. 2006;118:e914–e920
  50. Grau RG. Churg-Strauss syndrome: 2005–2008 update. Curr Rheumatol Rep. 2008;10:453–458

PII: S1521-6942(09)00076-X

doi: 10.1016/j.berh.2009.07.004

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 5 , Pages 679-688 , October 2009

Article Tools